Sarangapani Manda

619 total citations
42 papers, 539 citations indexed

About

Sarangapani Manda is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Sarangapani Manda has authored 42 papers receiving a total of 539 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Organic Chemistry, 12 papers in Molecular Biology and 4 papers in Pharmacology. Recurrent topics in Sarangapani Manda's work include Synthesis and biological activity (26 papers), Synthesis and Characterization of Heterocyclic Compounds (16 papers) and Synthesis and Biological Evaluation (7 papers). Sarangapani Manda is often cited by papers focused on Synthesis and biological activity (26 papers), Synthesis and Characterization of Heterocyclic Compounds (16 papers) and Synthesis and Biological Evaluation (7 papers). Sarangapani Manda collaborates with scholars based in India, United States and United Kingdom. Sarangapani Manda's co-authors include A. Rama Narsimha Reddy, Kiran Gangarapu, Jitendra Patel, Ankur Patel, Sanjay B. Bari, Gokul S. Talele, Sreekanth Thota, Harukuni Tokuda, Erik De Clercq and V. Jayathirtha Rao and has published in prestigious journals such as SHILAP Revista de lepidopterología, Advances in experimental medicine and biology and Chinese Chemical Letters.

In The Last Decade

Sarangapani Manda

39 papers receiving 507 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sarangapani Manda India 13 435 116 76 48 44 42 539
Ihsan A. Shehata Egypt 15 574 1.3× 140 1.2× 55 0.7× 44 0.9× 64 1.5× 35 734
Vinod Devaraji India 14 309 0.7× 163 1.4× 64 0.8× 91 1.9× 81 1.8× 28 505
Marwa A.M.Sh. El‐Sharief Egypt 16 668 1.5× 195 1.7× 66 0.9× 64 1.3× 70 1.6× 27 773
Kinga Ostrowska Poland 14 264 0.6× 155 1.3× 68 0.9× 46 1.0× 89 2.0× 35 410
Zabiulla Zabiulla India 13 391 0.9× 83 0.7× 61 0.8× 43 0.9× 62 1.4× 30 478
Silvia Burnelli Italy 13 510 1.2× 155 1.3× 43 0.6× 46 1.0× 78 1.8× 25 667
Darío C. Gerbino Argentina 12 329 0.8× 105 0.9× 44 0.6× 25 0.5× 67 1.5× 30 456
Mallinath H. Hugar India 6 362 0.8× 90 0.8× 46 0.6× 38 0.8× 49 1.1× 6 427
Süleyman Servi Türkiye 10 425 1.0× 112 1.0× 40 0.5× 43 0.9× 61 1.4× 39 542
Л. В. Аникина Russia 15 466 1.1× 197 1.7× 47 0.6× 17 0.4× 41 0.9× 75 663

Countries citing papers authored by Sarangapani Manda

Since Specialization
Citations

This map shows the geographic impact of Sarangapani Manda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarangapani Manda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarangapani Manda more than expected).

Fields of papers citing papers by Sarangapani Manda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarangapani Manda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarangapani Manda. The network helps show where Sarangapani Manda may publish in the future.

Co-authorship network of co-authors of Sarangapani Manda

This figure shows the co-authorship network connecting the top 25 collaborators of Sarangapani Manda. A scholar is included among the top collaborators of Sarangapani Manda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarangapani Manda. Sarangapani Manda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Manda, Sarangapani, et al.. (2026). Quorum‐Sensing Inhibitors as Potential Antibacterial Agents Against Staphylococcus aureus : A Comprehensive Review. Chemistry & Biodiversity. 23(1). e02013–e02013.
2.
Porika, Mahendar, et al.. (2025). Hesperidin as a potent telomerase inhibitor: Studies on its anticancer and anti-telomerase effects. Food Bioscience. 65. 106063–106063.
3.
Manda, Sarangapani, et al.. (2022). Design and synthesis of new series 6, 7-disubstituted-7H-purine analogues induce G2/M cell cycle arrest and apoptosis in human breast cancer SKBR3 cells via selective EGFR/HER2 dual kinase inhibition. International Journal of Pharmaceutical Sciences and Drug Research. 402–413. 1 indexed citations
5.
Badavath, Vishnu Nayak, et al.. (2019). Computational Studies of bis-2-Oxoindoline Succinohydrazides and their In Vitro Cytotoxicity. Current Computer - Aided Drug Design. 16(3). 270–280. 3 indexed citations
6.
Manda, Sarangapani, et al.. (2018). SYNTHESIS AND COMPARISON OF PEG-IBUPROFEN AND PEG-KETOPROFEN PRODRUGS BY IN VITRO AND IN VIVO EVALUATION. Journal of Drug Delivery and Therapeutics. 8(4). 1 indexed citations
7.
Manda, Sarangapani, et al.. (2018). Novel Imidazo [1, 2-a] Pyrazine Derivatives: Design, Synthesis, Antioxidant and Antimicrobial Evaluations. International Journal of Chemical Sciences. 16(3). 2 indexed citations
8.
Gangarapu, Kiran, et al.. (2017). Design, synthesis and molecular docking of novel structural hybrids of substituted isatin based pyrazoline and thiadiazoline as antitumor agents. Medicinal Chemistry Research. 26(4). 819–829. 28 indexed citations
10.
Alla, Manjula, et al.. (2015). Solvent-free one-pot synthesis of polysubstituted tetrahydropyrimidines and their antioxidant and antimicrobial properties. Research on Chemical Intermediates. 42(2). 923–937. 4 indexed citations
11.
Gangarapu, Kiran, et al.. (2015). In silico and in vitro studies of novel 7-azaindole and 7-azaisatin derivatives as potent anticancer agents. Medicinal Chemistry Research. 24(9). 3412–3422. 16 indexed citations
12.
Kishore, K., et al.. (2014). ANTIINFLAMMATORY AND ANTIOXIDANT ACTIVITIES OF 2-AMINO-N-(SUBSTITUTED ALKYL) BENZOXAZOLE-5-CARBOXAMIDE DERIVATIVES. International Journal of Pharmacy and Pharmaceutical Sciences. 6(7). 311–314. 2 indexed citations
13.
Manda, Sarangapani, et al.. (2014). SYNTHESIS OF PRODRUGS OF MEFENAMIC ACID AND THEIR IN VIVO EVALUATION. 6(7). 437–442. 4 indexed citations
14.
Gangarapu, Kiran, Sarangapani Manda, Sreekanth Thota, et al.. (2013). Synthesis of thiocarbohydrazide and carbohydrazide derivatives as possible biologically active agents. Medicinal Chemistry Research. 23(2). 1046–1056. 38 indexed citations
15.
Manda, Sarangapani, et al.. (2013). Synthesis and Screening of Some Novel 2-[5-(Substituted phenyl)-[1,3,4]oxadiazol-2-yl]-benzoxazoles as Potential Antimicrobial Agents. Journal of the Korean Chemical Society. 57(2). 221–226. 11 indexed citations
16.
Kumar, Chebolu Naga Sesha Sai Pavan, et al.. (2012). A facile route for the synthesis 1,4-disubstituted tetrazolone derivatives and evaluation of their antimicrobial activity. Medicinal Chemistry Research. 22(7). 3329–3340. 8 indexed citations
17.
Dharani, Sathish, et al.. (2011). Stereospecific dissolution of inclusion complexes of amlodipine base and its besylate enantiomers with hydroxypropyl-β-cyclodextrin. Latin American Journal of Pharmacy. 1 indexed citations
18.
Reddy, A. Rama Narsimha, et al.. (2011). Synthesis, characterization and anticancer activity of certain 3-{4-(5-mercapto-1,3,4-oxadiazole-2-yl)phenylimino}indolin-2-one derivatives. Saudi Pharmaceutical Journal. 19(3). 153–158. 84 indexed citations
19.
Dharani, Sathish, et al.. (2010). P-Glycoprotein- and cytochrome P-450-mediated herbal drug interactions. Drug metabolism and drug interactions. 25(1-4). 3–16. 22 indexed citations
20.
Patel, Ankur, Sanjay B. Bari, Gokul S. Talele, Jitendra Patel, & Sarangapani Manda. (2006). Synthesis and Antimicrobial Activity of Some New Isatin Derivatives. Iranian journal of pharmaceutical research. 5(4). 249–254. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026